Cochrane Abstracts
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Palivizumab for Prophylaxis Against Respiratory Syncytial Virus Infection in Children With Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed January 16, 2025.
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Palivizumab for Prophylaxis Against Respiratory Syncytial Virus Infection in Children With Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis
ID - 431470
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431470/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
